Skip to main content
Contact Us
Subscribe
E-Edition
41°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Karyopharm Therapeut
(NQ:
KPTI
)
1.480
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
157
Open
1.480
Bid (Size)
1.450 (108)
Ask (Size)
1.520 (60)
Prev. Close
1.480
Today's Range
1.480 - 1.480
52wk Range
0.6174 - 4.870
Shares Outstanding
114,010,448
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript
February 29, 2024
KPTI earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Performance
YTD
+64.23%
+64.23%
1 Month
+12.98%
+12.98%
3 Month
+60.26%
+60.26%
6 Month
+8.03%
+8.03%
1 Year
-57.83%
-57.83%
More News
Read More
Karyopharm Therapeutics's Earnings: A Preview
February 28, 2024
Via
Benzinga
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
February 25, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 05, 2024
Via
Benzinga
Earnings Preview For Karyopharm Therapeutics
November 01, 2023
Via
Benzinga
6 Analysts Have This to Say About Karyopharm Therapeutics
August 03, 2023
Via
Benzinga
4 Analysts Have This to Say About Karyopharm Therapeutics
July 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 31, 2024
Via
Benzinga
Karyopharm Therapeutics (KPTI) Q3 2023 Earnings Call Transcript
November 02, 2023
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Stocks That Hit 52-Week Lows On Wednesday
August 30, 2023
Via
Benzinga
Karyopharm Therapeutics (KPTI) Q2 2023 Earnings Call Transcript
August 02, 2023
Via
The Motley Fool
Karyopharm's Selinexor Shows Progression-Free Survival of 27.4 Months In Endometrial Cancer With Certain Mutation
July 26, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 18, 2023
Via
Benzinga
CMG Stock Alert: Chipotle Announces International Expansion Plan
July 18, 2023
Via
InvestorPlace
Why Are Karyopharm Therapeutics Shares Gaining Today?
July 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 18, 2023
Via
Benzinga
Why Is CEL-SCI (CVM) Stock Down 23% Today?
July 18, 2023
Via
InvestorPlace
Why Is Masimo (MASI) Stock Down 30% Today?
July 18, 2023
Via
InvestorPlace
Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket
July 18, 2023
Via
Benzinga
Why Is Karyopharm Therapeutics (KPTI) Stock Up 21% Today?
July 18, 2023
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
July 18, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
July 17, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.